{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:30:50Z","timestamp":1785007850514,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.cyto.2017.12.020","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T18:29:27Z","timestamp":1514485767000},"page":"20-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa"],"prefix":"10.1016","volume":"103","author":[{"given":"D.","family":"Jim\u00e9nez-Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de la Varga-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ossorio-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Collantes-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Linares-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Suppl 1","key":"10.1016\/j.cyto.2017.12.020_b0005","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jaad.2015.07.045","article-title":"Pathophysiology of hidradenitis suppurativa: an update","volume":"73","author":"Prens","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.cyto.2017.12.020_b0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2017.12.020_b0015","article-title":"Recommendations for the management of comorbidity in hidradenitis suppurativa","author":"Dauden","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.cyto.2017.12.020_b0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.1016\/j.cyto.2017.12.020_b0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"Lima","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2017.12.020_b0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2017.12.020_b0035","doi-asserted-by":"crossref","first-page":"2450401","DOI":"10.1155\/2017\/2450401","article-title":"The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.cyto.2017.12.020_b0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaad.2015.08.052","article-title":"Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)","volume":"73","author":"Hessam","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2017.12.020_b0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2016.08.036","article-title":"Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa","volume":"76","author":"Montaudi\u00e9","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2017.12.020_b0050","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.cyto.2017.12.020_b0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40257-016-0220-6","article-title":"Adalimumab: a review in hidradenitis suppurativa","volume":"17","author":"Kim","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"issue":"6","key":"10.1016\/j.cyto.2017.12.020_b0060","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.cyto.2017.12.020_b0065","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/bjd.14976","article-title":"High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics","volume":"176","author":"Desai","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.cyto.2017.12.020_b0070","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"issue":"12","key":"10.1016\/j.cyto.2017.12.020_b0075","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.annder.2015.07.012","article-title":"\u00c9valuation clinique de la s\u00e9v\u00e9rit\u00e9 de l\u2019hidrad\u00e9nite suppur\u00e9e \u2013 maladie de Verneuil","volume":"142","author":"Revuz","year":"2015","journal-title":"Ann. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.cyto.2017.12.020_b0080","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.172.2.599","article-title":"Shedding of tumor necrosis factor receptors by activated human neutrophils","volume":"172","author":"Porteu","year":"1990","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cyto.2017.12.020_b0085","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2017.12.020_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-017-1074-y","article-title":"The critical role of macrophages in the pathogenesis of hidradenitis suppurativa","author":"Shah","year":"2017","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.12.020_b0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/BOR.0000000000000255","article-title":"The biology behind interleukin-6 targeted interventions","volume":"28","author":"Liu","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2017.12.020_b0100","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","article-title":"IL-6 regulates neutrophil trafficking during acute inflammation via STAT3","volume":"181","author":"Fielding","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.12.020_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12799","article-title":"Effects of tocilizumab on neutrophil function and kinetics","author":"Lok","year":"2017","journal-title":"Eur. J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.cyto.2017.12.020_b0110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ijd.12550","article-title":"Hidradenitis suppurativa: the role of immune dysregulation","volume":"53","author":"Kelly","year":"2014","journal-title":"Int. J. Dermatol."},{"issue":"10","key":"10.1016\/j.cyto.2017.12.020_b0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-015-1596-5","article-title":"Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients","volume":"307","author":"Riis","year":"2015","journal-title":"Arch. Dermatol. Res."},{"issue":"20","key":"10.1016\/j.cyto.2017.12.020_b0120","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn's disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"10.1016\/j.cyto.2017.12.020_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0001-7310(17)30007-8","article-title":"Management of patients with hidradenitis suppurativa","volume":"107","author":"Martorell","year":"2016","journal-title":"Actas Dermosifiliogr."},{"issue":"7","key":"10.1016\/j.cyto.2017.12.020_b0130","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jdv.14076","article-title":"Assessment of subclinical atherosclerosis in hidradenitis suppurativa","volume":"31","author":"Pascual","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cyto.2017.12.020_b0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2016.05.036","article-title":"Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis","volume":"251","author":"Piaserico","year":"2016","journal-title":"Atherosclerosis"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617303915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617303915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T01:25:56Z","timestamp":1535160356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617303915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"alternative-id":["S1043466617303915"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.12.020","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}